Beautiful news. I pray that this research bears fruit, and that it is disseminated.
Unfortunately, it has been found that cancer tends to be genetically heterogeneous even within the same tumor. A treatments may kill off one cell line and thereby slow a tumor, but also spare other lines that then begin to multiply with renewed vigor.
Makes me wonder why the article only mentions the 3 big companies.
The comments at the site point out that the article completely overlooks the work of Cellceutix (CTIX) whose compound is currently in actual Phase 1 human testing at Dana Farber (Harvard) and whose drug has performed in the lab tests much better than anything out there. Multiple other tests for CTIX drugs scheduled for 2013.
Whichever company solves this P53 challenge may have the biggest breakthrough in cancer treatment ever.
Thanks, neverdem. Good news in dark times.
>> Advocacy groups should shift from fund-raising for particular cancers to pushing for research aimed at many kinds of cancer at once
Very close to a breast cancer survivor and a rare cancer survivor. It would be good to see an umbrella approach to the fund-raising efforts. No cancer group is too small.
Pardon my cynicism, an effective cure for cancer would cost too much. Big Pharma (FDA) won’t allow it.
Thanks for the information. My wife has myeloma with genetic complications. This gives us hope for the long term.
This is why health care competition is the best solution to our medical woes. The FedGov has the Constitutional authority through the Commerce Clause to end anti-competitive practices instituted by the states. Obamacare simply worsens the situation.
Most hospital systems are planning for a 60% cut in their Medicare payments. 60% cuts will kill patients and the system.